Main Session
Sep
29
LBA 01 - Late-breaking Abstract Session
LBA 01 - TRIDENT: Phase 3 Trial of Tumor Treating Fields (TTFields) Therapy Concurrent with Temozolomide (TMZ) Radiochemotherapy Followed by Maintenance TMZ and TTFields for Newly Diagnosed Glioblastoma (ndGBM)
Presenter(s)
Wenyin Shi, MD, PhD - Thomas Jefferson University, Philadelphia, PA